Tompkins Financial Corp Charles River Laboratories International, Inc. Transaction History

Tompkins Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 17, 2019	SELL	$123.4 - $148.55 $15,054 - $18,123	-122 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$104.82 - $146.73 $8,071 - $11,298	-77 Reduced 38.69%	122 $18,000
Q1 2019 Apr 17, 2019	BUY	$104.82 - $146.73 $8,071 - $11,298	77 Added 63.11%	199 $27,000
Q4 2018 Jan 22, 2019	SELL	$105.09 - $137.23 $8,091 - $10,566	-77 Reduced 38.69%	122 $14,000
Q3 2018 Oct 18, 2018	SELL	$112.11 - $134.54 $9,641 - $11,570	-86 Reduced 30.18%	199 $27,000
Q1 2018 Apr 26, 2018	BUY	$98.19 - $115.2 $27,984 - $32,832	285 New	285 $30,000
Q4 2017 Jan 24, 2018	SELL	$100.43 - $118.09 $4,519 - $5,314	-45 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$96.72 - $109.26 $4,352 - $4,916	45	45 $5,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Tompkins Financial Corp with notifications on news.